HealthMed Services, Ltd. Completes Merger With DRS Technologies, Inc.
June 08 2011 - 7:30AM
Marketwired
HealthMed Services, Ltd. (PINKSHEETS: HEME) is pleased to announce
that its recently-acquired subsidiary, DRS Technologies, Inc., has
been merged with and into HealthMed Services, Ltd.
The merger, which took effect on June 6, 2011, was completed in
order to fully absorb into the Company the proprietary technology
of DRS Technology. The DRS Technology business model is to
distribute and market diabetes test kits through retail outlets and
online, enabling consumers in a totally confidential manner to
predict their propensity to contract diabetes based on testing
their saliva to detect certain significant proteins that may be
present. Results of the tests are available online only to the
individual purchaser of a test kit through confidential codes
provided in the kit, without revealing the identity of the user to
anyone.
About HealthMed Services, Ltd.
The Company has acquired the rights from Dr. Henry J. Smith to
an improved Donor Organ Transport System (Patent Pending). By
reconditioning the donor organ such as the heart, kidney or liver
and extending the period of time for transport, it will be possible
to improve the success rates of transplants. Also, by having a
device that can maintain the organ for an extended period in vitro,
it will be possible to test drugs on isolated organs in vitro
before starting clinical trials on patients. The Company has made
significant progress in its research program and has a working
model of a portable organ transport device. Dr. Smith has completed
the initial research studies showing that isolated donor organs
could be kept alive for an extended period of time using the organ
transport system developed. Research has indicated this device to
be what is needed and desired for the practice of medicine, and it
represents strong possibility to be the foundation for an
enterprise highly profitable to the Company and its shareholders.
In addition, the Company has recently expanded its business model
to include a confidential testing program for individuals to test
for the propensity to contract diabetes.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements," as that
term is defined in Section 27A of the United States Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934.
Statements in this press release which are not purely historical
are forward-looking statements and include any statements regarding
beliefs, plans, expectations or intentions regarding the future.
Such forward-looking statements include, among other things, the
development, costs and results of our exploration program at our
properties and any anticipated future production. Actual results
could differ from those projected in any forward-looking statements
due to numerous factors. Such factors include, among others, the
inherent uncertainties associated with cleaning fluid and
development stage exploration companies. These forward-looking
statements are made as of the date of this news release, and we
assume no obligation to update the forward-looking statements, or
to update the reasons why actual results could differ from those
projected in the forward-looking statements. Although we believe
that the beliefs, plans, expectations and intentions contained in
this press release are reasonable, there can be no assurance that
such beliefs, plans, expectations or intentions will prove to be
accurate. Investors should consult all of the information set forth
herein and should also refer to the risk factors disclosure
outlined in our annual report, quarterly reports or current reports
filed from time-to-time with OTC Markets, Inc.
Contact: Richard E. Floegel (619) 248-6868
Healthmed Services (PK) (USOTC:HEME)
Historical Stock Chart
From May 2024 to Jun 2024
Healthmed Services (PK) (USOTC:HEME)
Historical Stock Chart
From Jun 2023 to Jun 2024